相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resveratrol: A review of preclinical studies for human cancer prevention
Mohammad Athar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Leukemia stem cells in a genetically defined murine model of blast-crisis CML
Sarah J. Neering et al.
BLOOD (2007)
Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase
Chang Eun Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition
A. Jacquel et al.
ONCOGENE (2007)
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
Anjana Bhardwaj et al.
BLOOD (2007)
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line
A. Morotti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Cytotoxic and biochemical effects of 3,3',4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells
Zsuzsanna Horvath et al.
EXPERIMENTAL HEMATOLOGY (2006)
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice
Mengwei Zang et al.
DIABETES (2006)
Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats
Min Shen et al.
VASCULAR PHARMACOLOGY (2006)
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis
A Jacquel et al.
ONCOGENE (2006)
Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation
J Rangatia et al.
LEUKEMIA (2006)
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
S Koschmieder et al.
BLOOD (2005)
Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells
K Kohmura et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it
T Kawano et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
LS Steelman et al.
LEUKEMIA (2004)
Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells
C Luzi et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
M Herrant et al.
ONCOGENE (2004)
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
M van de Wetering et al.
EMBO REPORTS (2003)
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
FX Mahon et al.
BLOOD (2003)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Specific inhibition of bcr-abl gene expression by small interfering RNA
M Scherr et al.
BLOOD (2003)
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
NJ Donato et al.
BLOOD (2003)
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model
RB Ren
ONCOGENE (2002)
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes
XH Gao et al.
JOURNAL OF NUTRITION (2002)
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
CL Sawyers et al.
BLOOD (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation
CM Rodrigue et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
